ジェイファーマ announced that it had received a grant award decision under AAMED's Global Research and Development Support Program for Treatments for Intractable and Rare Diseases and that the grant-funded project would commence. The announcement was made at 15:30 on 30 October 2026.
ジェイファーマ announced that it had received a grant award decision under the Global Research and Development Support Program for Treatments for Intractable and Rare Diseases and that the grant-funded project would commence. The date was 30 October 2026.
The grant award decision and commencement of the grant-funded project were formally communicated through AAMED, confirming the start of the research and development activities covered by the company's support.
The release does not state the specific grant amount or provide details of the research covered. Instead, it focuses on the establishment of the event and the commencement of the project.
The announcement was presented as material on Nikkei Company Information DIGITAL and reported in conjunction with ジェイファーマ's disclosure.